CONNECT WITH US
eCommerce

eCommerce

EU and India Agree to Expand Research Partnership

Global Cosmetics News logo

Published on

Add as a preferred source on Google
EU and India Agree to Expand Research Partnership

THE WHAT? The European Union and India have concluded negotiations on India’s participation in the €93.5 billion Horizon Europe research and innovation programme, creating new opportunities for scientific collaboration, biotechnology development and industrial innovation.

THE DETAILS The agreement would allow Indian researchers, universities and businesses to receive direct funding and lead collaborative projects under Horizon Europe’s Pillar II, which supports research across healthcare, digital technologies, industrial innovation, climate, energy and the bioeconomy. India’s participation is expected to begin in January 2027, subject to the formal signing of the agreement and completion of the necessary approval procedures. The development builds on the existing EU–India Agreement for Scientific and Technological Cooperation, which has been extended until 2030. Horizon Europe currently includes 23 associated non-EU countries, with India’s proposed participation strengthening international research partnerships and access to scientific expertise. 

THE WHY? The agreement could create new opportunities for cosmetics manufacturers, ingredient suppliers and biotechnology companies to collaborate on advanced materials, sustainable formulations and AI-driven research. Greater access to European research funding and international scientific partnerships could support joint innovation projects between Indian and European cosmetics businesses, particularly in biotechnology, sustainable manufacturing and next-generation ingredients.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.